A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy
Francis H. Grand, Sameena Iqbal, Lingyan Zhang, Nigel H. Russell, Andrew Chase, Nicholas C.P. CrossVolume:
35
Year:
2007
Language:
english
Pages:
5
DOI:
10.1016/j.exphem.2007.07.002
File:
PDF, 511 KB
english, 2007